Adjuvant Pembrolizumab in Resected Stage III Melanoma Reply

被引：0
|
作者：
Eggermont, Alexander M. M. [1 ]
Robert, Caroline [1 ]
Suciu, Stefan [2 ]
机构：
[1] Gustave Roussy Canc Campus Grand Paris, Villejuif, France
[2] European Org Res & Treatment Canc Headquarters, Brussels, Belgium
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 06期
关键词：
HIGH-RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：593 / 595
页数：4
相关论文
共 50 条
  • [41] Adjuvant Nodal Radiation Therapy for Melanoma in the Era of Immunotherapy
    Mitra, Devarati
    Bishop, Andrew
    Guadagnolo, B. Ashleigh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (01): : 164 - 169
  • [42] Adjuvant Ipilimumab in High-Risk Uveal Melanoma
    Fountain, Eric
    Bassett, Roland L.
    Cain, Suzanne
    Posada, Liberty
    Gombos, Dan S.
    Hwu, Patrick
    Bedikian, Agop
    Patel, Sapna P.
    CANCERS, 2019, 11 (02):
  • [43] Evidence for Radiation Therapy in Stage III Locoregionally Advanced Cutaneous Melanoma in the Post-Immunotherapy Era: A Literature Review
    Zhou, Jennifer
    Wuthrick, Evan
    CANCERS, 2024, 16 (17)
  • [44] Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
    Peng, Jianhong
    Li, Weihao
    Fan, Wenhua
    Zhou, Wenhao
    Zhu, Ying
    Li, Xueying
    Pan, Zhizhong
    Lin, Xiaoping
    Lin, Junzhong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [45] Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group
    Dahl, Olav
    Fluge, Oystein
    Carlsen, Erik
    Wiig, Johan N.
    Myrvold, Helge E.
    Vonen, Barthold
    Podhorny, Nina
    Bjerkeset, Ottar
    Eide, Tor Jack
    Halvorsen, Tore B.
    Tveit, Kjell Magne
    ACTA ONCOLOGICA, 2009, 48 (03) : 368 - 376
  • [46] Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal Melanoma
    Takayesu, Jamie S. K.
    Parvathaneni, Upendra
    Laramore, George E.
    Panjwani, Neil
    Sillings, Jennifer
    Futran, Neal D.
    Humphreys, Ian M.
    Jafari, Aria
    Abuzeid, Waleed M.
    Barber, Brittany
    Marchiano, Emily
    Lee, Sylvia M.
    Thompson, John A.
    Hall, Evan
    Bhatia, Shailender
    Rodriguez, Cristina P.
    Liao, Jay J.
    CANCER REPORTS, 2025, 8 (02)
  • [47] Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting
    Herrscher, Hugo
    Robert, Caroline
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (02) : 106 - 113
  • [48] 2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
    Bedke, Jens
    Albiges, Laurence
    Capitanio, Umberto
    Giles, Rachel H.
    Hora, Milan
    Lam, Thomas B.
    Ljungberg, Borje
    Marconi, Lorenzo
    Klatte, Tobias
    Volpe, Alessandro
    Abu-Ghanem, Yasmin
    Dabestani, Saeed
    Fernandez-Pello, Sergio
    Hofmann, Fabian
    Kuusk, Teele
    Tahbaz, Rana
    Powles, Thomas
    Bex, Axel
    EUROPEAN UROLOGY, 2022, 81 (02) : 134 - 137
  • [49] Reply: "Adjuvant'' Hyperthermic Intraperitoneal Chemotherapy: A Call to Action
    Morris, David L.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S616 - S616
  • [50] The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis
    Danish, Hasan H.
    Patel, Kirtesh R.
    Switchenko, Jeffrey M.
    Gillespie, Theresa W.
    Jhaveri, Jaymin
    Chowdhary, Mudit
    Abugideiri, Mustafa
    Delman, Keith A.
    Lawson, David H.
    Khan, Mohammad K.
    MELANOMA RESEARCH, 2016, 26 (06) : 595 - 603
12345